Showing results (141-150 of 280) with videos related to

Sort By:
Pageof 28
The Lancet. Haematology|June 7, 2016
Potentially avoidable hospital admissions in older patients with acute myeloid leukaemia in the USA: a retrospective analysisAreej El-Jawahri, Tanya Keenan, Gregory A Abel, et al.
Cancer Cell|February 15, 2014
SYK is a critical regulator of FLT3 in acute myeloid leukemiaAlexandre Puissant, Nina Fenouille, Gabriela Alexe, et al.
Blood Advances|January 15, 2026
Stratifying Survival: The Role of Social Determinants of Health on AML Outcomes by ELN 2022 CriteriaShai Shimony, Yating Wang, Angel M Cronin, et al.
Cancer|July 13, 2019
Outcomes for older adults with acute myeloid leukemia after an intensive care unit admissionSamuel D Slavin, Alyssa Fenech, Amanda L Jankowski, et al.
Blood Advances|September 18, 2024
Risk of bleeding in patients with essential thrombocythemia and extreme thrombocytosisRathnam K Venkat, Robert A Redd, Amyah C Harris, et al.
Blood|August 12, 2006
Phase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and pharmacodynamicsDaniel J DeAngelo, Richard M Stone, Mark L Heaney, et al.
Blood Advances|May 31, 2022
Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosisAndreas Reiter, Juliana Schwaab, Daniel J DeAngelo, et al.
The Journal of Clinical Investigation|September 12, 2017
Neutrophil FcγRIIA promotes IgG-mediated glomerular neutrophil capture via Abl/Src kinasesHiroshi Nishi, Kazuhiro Furuhashi, Xavier Cullere, et al.
Investigational New Drugs|April 27, 2011
Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemiaSimona Lapusan, Maria B Vidriales, Xavier Thomas, et al.
Blood|June 5, 2010
P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808Jonathan E Kolitz, Stephen L George, Guido Marcucci, et al.
Pageof 28